Abstract     Description     Claims     Drawing  

CN102154253A   [0031]  [0031] 
WO9704801A   [0054] 
US3773919A   [0058] 
EP58481A   [0058] 

Barany and Solid-Phase Peptide Synthesis   [0047] 
J. Am. Chem. Soc.   [0047] 
Solid Phase Peptide Synthesis   [0047] 
Mini Rev. Med Chem.   [0047] 
Protein Pept Lett.   [0047] 
From Genes to Clones   [0052] 
Immunol. Rev.   [0052] 
J. Immunol.   [0052] 
Remington's Pharmaceutical Sciences   [0054]  [0056] 
J. Biomed. Mater. Res.   [0058] 
Chem. Tech.   [0058] 
Biopolymers   [0058] 
Development of the endochondral skeleton [J   [0130] 
Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts [J   [0130] 
Does low bone mineral density start in postteenage years in women with type 1 diabetes [J   [0130] 
Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance [J   [0130] 
Diabetes and bone loss at the hip in older black and white adults [J   [0130] 
The Investigation and evaluation of bone mineral density in type 2 diabetic women [J   [0130] 
Molecular, endocrine, and genetic mechanisms of arterial calcification [J   [0130] 
Usefulness of bone mineral density to predict significant coronary artery disease [J   [0130] 
Aortic calcification and the risk of osteoporosis and fractures [J   [0130] 
Title: Molecular perspectives of vitamin D in osteoblast and association between osteoporosis and artery calcification   [0130] 
Vitamin D and aging: old concepts and new insights   [0130] 
Extracellular matrix degradation   [0130] 
Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator   [0130] 
Tissue cooperation in a proteolytic cascade activating human interstitial collagenase   [0130] 
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes   [0130] 
A cellular binding site for the Mr 55, 000 form of the human plasminogen activator, urokinase   [0130] 
Structural relationship between ''glutamic acid'' and ''lysine'' forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography   [0130] 
Cell-associated plasminogen activation: regulation and physiological functions   [0130] 
Synthesis of human plasminogen by the liver   [0130] 
Biochemistry of plasminogen   [0130] 
Amino-acid sequence of activation cleavage site in plasminogen: homology with ''pro'' part of prothrombin   [0130] 
Basic and clinical aspects of fibrinolysis and thrombolysis   [0130] 
Proteinases and extracellular matrix remodeling   [0130] 
Biology and biochemistry of proteinases in tumor invasion   [0130] 
Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling   [0130] 
Growth factor control of extracellular proteolysis   [0130] 
The urokinase-type plasminogen activator system in cancer metastasis: a review   [0130] 
Proteolytic control of growth factor availability   [0130] 
Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential [J   [0130] 
Simplified recombinant plasmin: production and fu-nctional comparison of a novel thrombolytic molecule with plasma-derived plasmin [J   [0130] 
The primary structure of human plasminogen: Isolation of two lysine-binding fragments and one ''mini''-plasminogen (MW, 38, 000) by elastase-catalyzed-specific limited proteolysis [J   [0130] 
Recombinant human microplasmin: production and potential therapeutic properties [J   [0130] 
Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization J   [0130] 
Bone Resorption Induced by 1a,25 Dihydroxyvitamin D3 In Vivo Is Not Altered by Inactivation of the Plasminogen Activator Inhibitor 1   [0130] 
Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process   [0130] 
The correlation between bone histomorphometry and serum alkaline phosphatase in ovariectomized rats   [0130] 
Perspective: The diagnosis of osteoporosis   [0130] 
The application of the bone metabolic markers and bone mineral density in osteoporosis   [0130] 
Arterioscler Thromb   [0130] 
Npp1 promotes atherosclerosis in ApoE knockout mice   [0130] 
Severe hyercholestrolemia and antherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells   [0130] 
Spontaneous hypeicholeserolemia and arterial leision in mice lacking apolipoprotrin E [J   [0130] 
Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density   [0130] 
Interferon-g Plays a Role in Bone Formation In Vivo and Rescues Osteoporosis in Ovariectomized Mice   [0130] 
Neuropeptide Y-based recombinant peptides ameliorate bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization   [0130] 
Inhibitor of differentiation 3, a transcription factor regulates hyperlipidemia associated kidney disease   [0130] 
Extracts of Rhizoma Polygonati Odorati Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice   [0130] 
Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women   [0130] 
Oxidized low density lipoprotein, stem cells, and atherosclerosis   [0130]